000 | 00878 a2200229 4500 | ||
---|---|---|---|
005 | 20250515150557.0 | ||
264 | 0 | _c20111110 | |
008 | 201111s 0 0 eng d | ||
022 | _a1205-7088 | ||
024 | 7 |
_a10.1093/pch/12.5.373 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCheng, Anita | |
245 | 0 | 0 |
_aThe impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families. _h[electronic resource] |
260 |
_bPaediatrics & child health _cMay 2007 |
||
300 |
_a373-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aTithecott, Gary A | |
700 | 1 | _aEdwards, Wendy E | |
700 | 1 | _aJohnston, Ian G | |
773 | 0 |
_tPaediatrics & child health _gvol. 12 _gno. 5 _gp. 373-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/pch/12.5.373 _zAvailable from publisher's website |
999 |
_c18486492 _d18486492 |